RIL
JANX icon

Rothschild Investment LLC’s Janux Therapeutics JANX Stock Holding History

Rothschild Investment LLC’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.7K Buy
176
+94
+115% +$1.36K ﹤0.01% 2626
2026
Q1 		$1.14K Buy
+82
New +$1.12K ﹤0.01% 2813
2025
Q4 		– Sell
-50
Closed -$1.22K – 3466
2025
Q3 		$1.22K Sell
50
-45
-47% -$1.1K ﹤0.01% 2503
2025
Q2 		$2.19K Buy
95
+50
+111% +$1.32K ﹤0.01% 2012
2025
Q1 		$1.22K Buy
45
+5
+13% +$188 ﹤0.01% 2224
2024
Q4 		$2.14K Buy
40
+5
+14% +$264 ﹤0.01% 1757
2024
Q3 		$1.59K Buy
35
+25
+250% +$1.09K ﹤0.01% 1851
2024
Q2 		$419 Buy
+10
New +$470 ﹤0.01% 2129

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Rothschild Investment LLC's JANX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Janux Therapeutics (JANX) stake by 115% in Q2 2026, buying an estimated $1.36K and bringing the position to 176 shares worth $2.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2626.

Rothschild Investment LLC first reported a position in JANX in Q2 2024 and has held it in 8 quarters since. 197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Rothschild Investment LLC held 176 shares of Janux Therapeutics worth $2.7K as of Q2 2026.
  • Rothschild Investment LLC bought 94 Janux Therapeutics shares in Q2 2026, an estimated $1.36K.
  • Janux Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2626 holding.
  • Rothschild Investment LLC first reported a position in Janux Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.